GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007178 describes the biological process in which an extracellular ligand binds to a cell-surface receptor possessing intrinsic serine/threonine kinase activity, triggering a signaling cascade that ultimately regulates downstream cellular responses such as transcription.
• This pathway is distinct from tyrosine kinase receptor signaling because the receptor phosphorylates serine and threonine residues on target proteins, not tyrosine.
• Key receptor families include TGF-beta receptors, BMP receptors, and plant receptor-like kinases such as FERONIA, which control diverse processes from immune signaling to auxin responses.
• The pathway is highly conserved across eukaryotes and regulates cell growth, differentiation, immune responses, and development.
• Dysregulation of serine/threonine kinase receptor signaling is implicated in cancer, fibrosis, and developmental disorders, making it a major therapeutic target.
• CRISPR-based knockout, knock-in, and point-mutation models are essential for dissecting the causal roles of individual components in this pathway.
Description
The cell surface receptor protein serine/threonine kinase signaling pathway (GO:0007178) is a fundamental biological process that converts extracellular cues into intracellular responses. It begins when a ligand binds to a receptor on the target cell surface that possesses serine/threonine kinase activity, and it ends with the regulation of downstream cellular processes, often including changes in gene transcription. This pathway is critical for metazoan development, tissue homeostasis, and immune regulation, and its components are frequently mutated in human diseases. In plants, homologous receptor kinases such as FERONIA mediate immune signaling and auxin responses, underscoring the deep evolutionary conservation of this mechanism. Researchers study GO:0007178 to understand how cells interpret environmental signals and to identify therapeutic targets for cancer, fibrosis, and developmental disorders. The pathway also intersects with other signaling modules, including G protein-coupled receptor kinase regulation and metabolic signaling, making it a central node in cellular communication.
cell surface receptor protein serine/threonine kinase signaling pathway At A Glance
| GO ID | GO:0007178 |
|---|---|
| GO term | cell surface receptor protein serine/threonine kinase signaling pathway |
| Ontology | biological_process |
| Synonym | transmembrane receptor protein serine/threonine kinase signaling pathway; transmembrane receptor protein serine/threonine kinase signalling pathway |
| Major function | Transduces extracellular ligand signals via receptor serine/threonine kinase activity to regulate downstream cellular processes such as transcription |
| Receptor type | Cell surface receptors with intrinsic serine/threonine kinase domains, including TGF-beta and BMP receptor families |
| Ligand examples | TGF-beta, BMPs, and plant peptides such as RALF |
| Downstream effectors | SMAD proteins, TIR1/AFB2, and other signaling intermediates |
| Evolutionary conservation | Present in metazoans and plants, with plant receptor kinases like FERONIA controlling immune and auxin responses |
What Is GO:0007178?
GO:0007178, cell surface receptor protein serine/threonine kinase signaling pathway, is defined as the series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. This process is also known as the transmembrane receptor protein serine/threonine kinase signaling pathway. It encompasses ligand binding, receptor activation, phosphorylation of downstream substrates on serine and threonine residues, and propagation of the signal to effector proteins and transcription factors.
Why Is cell surface receptor protein serine/threonine kinase signaling pathway Important in Cell Biology?
GO:0007178 is essential because it governs how cells respond to a vast array of extracellular signals, from growth factors to immune cues, and its dysregulation underlies numerous human diseases including cancer, fibrosis, and developmental syndromes. Understanding this pathway provides mechanistic insight into cell fate decisions, tissue regeneration, and host-pathogen interactions, and it offers a rich source of therapeutic targets for small-molecule inhibitors and biologics.
• Controls fundamental processes such as cell proliferation, differentiation, and apoptosis through serine/threonine phosphorylation cascades.
• Mutations in receptor serine/threonine kinases and their downstream effectors are linked to cancers and developmental disorders.
• Plays a central role in immune signaling, as shown by TLR pathways and plant FERONIA-mediated immunity.
• Regulates metabolic and hormonal responses, including leptin signaling and auxin-mediated root gravitropism.
• Influences tissue regeneration, with relevance to liver regeneration and stem cell maintenance.
• Provides targets for drug discovery, including kinase inhibitors for oncology and fibrosis.
• Serves as a paradigm for understanding signal transduction mechanisms across eukaryotes.
• Enables synthetic biology approaches to engineer receptor-ligand specificity for agricultural and biomedical applications.
What Happens During cell surface receptor protein serine/threonine kinase signaling pathway?
Ligand binding and receptor activation
In simple terms: A signal molecule docks onto a receptor on the cell surface, switching the receptor on.
The pathway begins when an extracellular ligand, such as a TGF-beta family member or a plant peptide like RALF, binds to the extracellular domain of a cell surface receptor that possesses serine/threonine kinase activity. This binding induces conformational changes that lead to receptor oligomerization and activation of the intracellular kinase domain. In plants, FERONIA is a receptor kinase that perceives RALF peptides to control immune signaling and growth.
Receptor autophosphorylation and substrate recruitment
In simple terms: The activated receptor adds phosphate groups to itself and to nearby proteins, passing the message along.
Upon activation, the receptor kinase phosphorylates serine and threonine residues on itself (autophosphorylation) and on downstream substrates. This creates docking sites for signaling intermediates such as SMAD proteins in metazoans or TIR1/AFB2 in plants. The specificity of substrate recruitment is determined by the receptor's kinase domain and accessory proteins.
Signal propagation to downstream effectors
In simple terms: The message travels through a chain of proteins inside the cell, often reaching the nucleus.
Phosphorylated substrates propagate the signal through a cascade of protein-protein interactions and post-translational modifications. For example, in TGF-beta signaling, activated SMADs form complexes that translocate to the nucleus to regulate transcription. In plant auxin signaling, FERONIA-mediated oxidation of TIR1/AFB2 stimulates auxin responses. The pathway can also intersect with other signaling modules, such as G protein-coupled receptor kinases, to fine-tune the response.
Regulation of downstream cellular processes
In simple terms: The signal ultimately changes what the cell does, such as turning genes on or off.
The endpoint of GO:0007178 is the regulation of a downstream cellular process, frequently transcription. This can involve direct phosphorylation of transcription factors or indirect modulation through signaling intermediates. In stomatal development, receptor kinase signaling controls the expression of genes that determine cell fate. Similarly, leptin signaling through serine/threonine kinases regulates metabolic gene expression.
Key Genes Involved in GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway
The following genes and proteins are core components or regulators of the cell surface receptor protein serine/threonine kinase signaling pathway, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFBR1 | Serine/threonine kinase receptor for TGF-beta; phosphorylates SMAD2/3 | Central to TGF-beta signaling; mutated in cancers and fibrosis |
| TGFBR2 | Serine/threonine kinase receptor that binds TGF-beta and activates TGFBR1 | Frequently mutated in colorectal and other cancers |
| BMPR1A | Serine/threonine kinase receptor for BMP ligands | Regulates bone and cartilage development; linked to juvenile polyposis |
| BMPR2 | Serine/threonine kinase receptor for BMPs | Mutations cause pulmonary arterial hypertension |
| ACVR1 | Serine/threonine kinase receptor for activin and BMP | Implicated in fibrodysplasia ossificans progressiva |
| SMAD2 | Downstream effector phosphorylated by TGFBR1 | Key mediator of TGF-beta transcriptional responses |
| SMAD3 | Downstream effector phosphorylated by TGFBR1 | Regulates fibrosis and cancer progression |
| SMAD4 | Co-SMAD that complexes with SMAD2/3 | Tumor suppressor lost in pancreatic and colon cancers |
| FER | Plant receptor kinase that perceives RALF peptides | Controls immune signaling and cell growth in Arabidopsis |
| TIR1 | Auxin receptor regulated by FERONIA-mediated oxidation | Links receptor kinase signaling to auxin responses |
| AFB2 | Auxin receptor regulated by FERONIA-mediated oxidation | Modulates auxin signaling in roots |
| TMK1 | Cell-surface auxin signaling kinase | Targets PIN2-mediated auxin fluxes for root gravitropism |
| ABP1 | Auxin-binding protein involved in TMK1 signaling | Regulates root gravitropism |
| ABL3 | Auxin-binding protein involved in TMK1 signaling | Regulates root gravitropism |
| LEPR | Leptin receptor that signals via serine/threonine kinases | Controls energy homeostasis and metabolism |
| GRK2 | G protein-coupled receptor kinase that cross-regulates signaling | Modulates receptor desensitization and crosstalk |
| TLR4 | Toll-like receptor that activates serine/threonine kinase cascades | Mediates innate immune signaling |
How Is cell surface receptor protein serine/threonine kinase signaling pathway Regulated?
The cell surface receptor protein serine/threonine kinase signaling pathway is tightly regulated at multiple levels. Receptor availability and ligand affinity are controlled by expression levels and post-translational modifications. Negative feedback mechanisms, such as inhibitory SMADs in TGF-beta signaling, dampen the pathway after activation. Cross-talk with other signaling modules, including G protein-coupled receptor kinases, can desensitize receptors or redirect signals. In plants, FERONIA activity is modulated by RALF peptides and by oxidation of downstream auxin receptors. Metabolic signals, such as leptin, also influence serine/threonine kinase cascades to regulate energy balance. These regulatory layers ensure appropriate signal duration and intensity, and their disruption contributes to disease.
cell surface receptor protein serine/threonine kinase signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFBR2 | Colorectal cancer, fibrosis | Knockout cell lines and mouse models |
| SMAD4 | Pancreatic cancer, juvenile polyposis | Conditional knockout in intestinal epithelium |
| BMPR2 | Pulmonary arterial hypertension | Knock-in of patient mutations in endothelial cells |
| ACVR1 | Fibrodysplasia ossificans progressiva | Point-mutation knock-in in mesenchymal stem cells |
| LEPR | Obesity, metabolic syndrome | Overexpression and knockout in hypothalamic neurons |
Cancer
Dysregulation of serine/threonine kinase receptor signaling is a hallmark of many cancers. Mutations in TGFBR2, SMAD4, and other pathway components lead to uncontrolled cell proliferation and metastasis. Loss of SMAD4 tumor suppressor function is common in pancreatic and colorectal cancers. Targeting this pathway with kinase inhibitors is an active area of oncology research.
Fibrotic and developmental disorders
Aberrant TGF-beta signaling drives fibrosis in lung, liver, and kidney, and mutations in BMPR2 cause pulmonary arterial hypertension. ACVR1 mutations lead to fibrodysplasia ossificans progressiva, a rare developmental disorder. These conditions highlight the pathway's role in tissue remodeling and bone formation.
Metabolic and immune diseases
Leptin signaling through serine/threonine kinases regulates energy homeostasis, and its dysfunction is linked to obesity and diabetes. Toll-like receptor pathways, which activate serine/threonine kinases, are critical for innate immunity and inflammation. Plant receptor kinases like FERONIA control immune responses, providing insights into conserved defense mechanisms.
From cell surface receptor protein serine/threonine kinase signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TGFBR2 drive tumorigenesis? | CRISPR knockout in colorectal cancer cell lines |
| How do BMPR2 mutations affect signaling? | Point-mutation knock-in in pulmonary endothelial cells |
| What is the role of FERONIA in immune signaling? | Knockout and tagged knock-in in Arabidopsis |
| How does TMK1 regulate root gravitropism? | Knockout and overexpression in plant roots |
| Does leptin receptor signaling require serine/threonine kinases? | Knockout and point-mutation in neuronal cell lines |
| Can SMAD4 loss be rescued by knock-in? | Knock-in of wild-type SMAD4 in pancreatic cancer cells |
How to Study the cell surface receptor protein serine/threonine kinase signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global serine/threonine phosphorylation changes | Mapping signaling networks |
| RNA-seq | Transcriptional changes | Identifying downstream gene expression programs |
| Live-cell imaging | Receptor localization and dynamics | Visualizing signal propagation |
| CRISPR knockout screening | Gene essentiality and pathway modifiers | Unbiased discovery of regulators |
| Western blot | Protein expression and phosphorylation status | Validating specific signaling events |
| Co-immunoprecipitation | Protein-protein interactions | Identifying receptor complexes |
| Luciferase reporter assays | Transcriptional activity of pathway-responsive promoters | Measuring pathway activation |
| Proximity labeling | Interactome of receptor kinases | Mapping signaling complexes |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies serine/threonine phosphorylation events downstream of receptor activation, providing a global view of pathway targets. This method is useful for mapping signaling networks and identifying novel substrates.
Transcriptional profiling
RNA-seq measures changes in gene expression following pathway activation or inhibition, revealing transcriptional outputs regulated by serine/threonine kinase signaling. It is commonly used to study TGF-beta and BMP responses.
Live-cell imaging
Fluorescently tagged receptors and downstream effectors allow real-time visualization of receptor trafficking, complex formation, and signal propagation. This approach is valuable for understanding spatiotemporal dynamics.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate the pathway, uncovering novel regulators and therapeutic targets. Such screens are particularly powerful for unbiased discovery.
How CRISPR Can Be Used to Study GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway
Knockout
CRISPR knockout of receptor serine/threonine kinases or downstream effectors abolishes pathway activity, enabling researchers to test necessity in processes such as immune signaling, development, and cancer. For example, knocking out FERONIA in Arabidopsis impairs RALF-mediated immune responses.
Point Mutation
Point mutations can be introduced to mimic patient-derived kinase-domain mutations or to abrogate catalytic activity, allowing precise structure-function analysis. This is particularly useful for studying oncogenic mutations in TGFBR2 or BMPR2.
Knock-in
Knock-in of tagged or fluorescently labeled receptors enables visualization and biochemical isolation of signaling complexes. Knock-in of disease-associated alleles in cell lines or animal models recapitulates human pathology.
Overexpression
Overexpression of wild-type or constitutively active receptors amplifies pathway output, useful for gain-of-function studies and for identifying downstream targets. It can also reveal dose-dependent effects on cellular phenotypes.
How EDITGENE Supports cell surface receptor protein serine/threonine kinase signaling pathway Research
Researchers studying cell surface receptor protein serine/threonine kinase signaling pathway-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of this pathway.
Contact EDITGENE today to design your custom CRISPR model for cell surface receptor protein serine/threonine kinase signaling pathway research.
Frequently Asked Questions About cell surface receptor protein serine/threonine kinase signaling pathway
What is GO:0007178?
GO:0007178 is the Gene Ontology term for cell surface receptor protein serine/threonine kinase signaling pathway, a biological process where extracellular ligands activate cell-surface receptors with serine/threonine kinase activity to regulate downstream cellular responses.
What genes are involved in cell surface receptor protein serine/threonine kinase signaling pathway?
Key genes include TGFBR1, TGFBR2, BMPR1A, BMPR2, ACVR1, SMAD2, SMAD3, SMAD4, FER, TIR1, AFB2, TMK1, LEPR, and TLR4, among others.
How does serine/threonine kinase receptor signaling differ from tyrosine kinase signaling?
Serine/threonine kinase receptors phosphorylate serine and threonine residues on substrates, whereas tyrosine kinase receptors phosphorylate tyrosine residues, leading to distinct downstream effectors and cellular outcomes.
What diseases are associated with defects in this pathway?
Defects are linked to cancers, fibrosis, pulmonary arterial hypertension, fibrodysplasia ossificans progressiva, and metabolic disorders such as obesity.
What are the main stages of this signaling pathway?
The pathway proceeds through ligand binding, receptor activation and autophosphorylation, substrate recruitment, signal propagation, and regulation of downstream cellular processes such as transcription.
How is this pathway studied in the lab?
Common methods include phosphoproteomics, RNA-seq, live-cell imaging, CRISPR screening, Western blotting, and co-immunoprecipitation.
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this pathway.
What is the role of FERONIA in this pathway?
FERONIA is a plant receptor kinase that perceives RALF peptides and controls immune signaling and auxin responses, serving as a model for serine/threonine kinase receptor function.
How does leptin signaling relate to this pathway?
Leptin signaling involves serine/threonine kinase cascades that regulate energy homeostasis, and its dysfunction is linked to metabolic diseases.
What are the therapeutic implications of targeting this pathway?
Inhibiting receptor serine/threonine kinases or their downstream effectors is a promising strategy for treating cancers, fibrosis, and other diseases driven by aberrant signaling.
Conclusion
The cell surface receptor protein serine/threonine kinase signaling pathway (GO:0007178) is a central mechanism by which cells convert extracellular signals into diverse biological responses. Its components are conserved across eukaryotes and are implicated in a wide range of human diseases, making it a prime target for therapeutic intervention. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate its complexity and translational potential.
References
- 1. Takeda K et al.. 2004. TLR signaling pathways.. Semin Immunol 16(1):3-9 PMID: 14751757
- 2. Stegmann M et al.. 2017. The receptor kinase FER is a RALF-regulated scaffold controlling plant immune signaling.. Science 355(6322):287-289 PMID: 28104890
- 3. Lu B et al.. 2024. FERONIA-mediated TIR1/AFB2 oxidation stimulates auxin signaling in Arabidopsis.. Mol Plant 17(5):772-787 PMID: 38581129
- 4. Rodriguez L et al.. 2025. ABP1/ABL3-TMK1 cell-surface auxin signaling targets PIN2-mediated auxin fluxes for root gravitropism.. Cell 188(22):6138-6150.e17 PMID: 41043433
- 5. Koniaris LG et al.. 2003. Liver regeneration.. J Am Coll Surg 197(4):634-59 PMID: 14522336
- 6. Sweeney G. 2002. Leptin signalling.. Cell Signal 14(8):655-63 PMID: 12020765
- 7. Zoulias N et al.. 2018. Molecular control of stomatal development.. Biochem J 475(2):441-454 PMID: 29386377
- 8. Pitcher JA et al.. 1998. G protein-coupled receptor kinases.. Annu Rev Biochem 67:653-92 PMID: 9759500
